(Q42943040)

11 November 2017

Low correlation between MIC and mutant prevention concentration (English)

1 reference

11 November 2017

2

1 reference

11 November 2017

Karl Drlica

1

1 reference

11 November 2017

Joseph M Blondeau

series ordinal

3

1 reference

11 November 2017

Christine Hesje

series ordinal

4

1 reference

11 November 2017

language of work or name

English

0 references

publication date

1 January 2006

1 reference

Antimicrobial Agents and Chemotherapy

11 November 2017

2

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

11 November 2017

50

1 reference

11 November 2017

1

1 reference

11 November 2017

403-404

1 reference

Evolution of ciprofloxacin-resistant Staphylococcus aureus in in vitro pharmacokinetic environments

11 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1346827

Mutant prevention concentration of garenoxacin (BMS-284756) for ciprofloxacin-susceptible or -resistant Staphylococcus aureus.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1346827

Mutant prevention concentration of gemifloxacin for clinical isolates of Streptococcus pneumoniae

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1346827

Selection of Streptococcus pneumoniae mutants having reduced susceptibility to moxifloxacin and levofloxacin.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1346827

Mutant prevention concentration as a measure of fluoroquinolone potency against mycobacteria

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1346827

Effect of fluoroquinolone concentration on selection of resistant mutants of Mycobacterium bovis BCG and Staphylococcus aureus

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1346827

Mutant prevention concentrations of ciprofloxacin for urinary tract infection isolates of Escherichia coli

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1346827

Comparison of minimal inhibitory and mutant prevention drug concentrations of 4 fluoroquinolones against clinical isolates of methicillin-susceptible and -resistant Staphylococcus aureus

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1346827

Mutant prevention concentrations of ciprofloxacin and enrofloxacin for Salmonella enterica

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1346827

Mutant prevention concentration of nalidixic acid, ciprofloxacin, clinafloxacin, levofloxacin, norfloxacin, ofloxacin, sparfloxacin or trovafloxacin for Escherichia coli under different growth conditions

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1346827

Restricting the selection of antibiotic-resistant mutant bacteria: measurement and potential use of the mutant selection window

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1346827

10.1128/AAC.50.1.403-404.2006

16 August 2018

Identifiers

DOI

1 reference

11 November 2017

1 reference

11 November 2017

1 reference